Compare FET & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FET | ANGO |
|---|---|---|
| Founded | 2005 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.7M | 453.0M |
| IPO Year | 2007 | 2004 |
| Metric | FET | ANGO |
|---|---|---|
| Price | $54.86 | $10.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 257.7K | ★ 266.5K |
| Earning Date | 05-25-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.64 | 81.92 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $791,474,000.00 | $291,010,000.00 |
| Revenue This Year | $4.23 | $9.11 |
| Revenue Next Year | $9.75 | $4.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $12.78 | $8.36 |
| 52 Week High | $63.58 | $13.99 |
| Indicator | FET | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 53.11 | 44.66 |
| Support Level | $25.54 | $10.37 |
| Resistance Level | $63.58 | $11.03 |
| Average True Range (ATR) | 2.94 | 0.34 |
| MACD | -0.90 | -0.04 |
| Stochastic Oscillator | 13.77 | 26.83 |
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.